[{"edinetCode":"E01064","endDate":"2017\/8\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":538.0,"averageTemporaryStaff":202.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4577020.0,"sharesOwendPercent":0.375,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":632.91,"equityRatio":0.457,"cashAndCashEquivalents":2872777000.0,"assets":16761744000.0,"currentAssets":8308954000.0,"fixedAsset":8452789000.0,"tangibleFixedAssets":7965706000.0,"intangibleFixedAssets":103067000.0,"investmentAndOtherAssets":384015000.0,"liabilities":9098003000.0,"currentLiabilities":7748956000.0,"shorTermDept":2732853000.0,"currentPortionOfBonds":111000000.0,"currentPortionOfLongTermDebt":1749105000.0,"fixedLiabilities":1349047000.0,"bonds":60000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":445022000.0,"netAsset":7663740000.0,"capitalStock":7672578000.0,"capital":1405498000.0,"capitalSurplus":1469539000.0,"accumulatedEarnings":4856824000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-8837000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":15141754000.0,"costOfSales":10533969000.0,"grossProfit":4607785000.0,"sgaExpenses":3538537000.0,"salaryAndBenefit":1162612000.0,"depreciationAndSGA":null,"RDExpenses":116114000.0,"operatingIncome":1069247000.0,"nonOperatingIncome":47853000.0,"nonOperatingExpenses":76692000.0,"interestExpense":65373000.0,"ordinaryProfit":1040408000.0,"extraordinaryGain":56860000.0,"extraordinaryLoss":459973000.0,"incomeBeforeTax":637295000.0,"incomeTaxes":171402000.0,"netIncome":465893000.0,"netIncomeAttributableToOwnersOfTheParentCompany":465893000.0,"comprehensiveIncome":472794000.0,"eps":38.48,"dilutedEps":null,"dividendPerShare":null,"per":21.4,"roe":0.062,"cashFlowFromOperatingActivities":525584000.0,"depreciationAndCashflowFromOperatingActivities":383281000.0,"cashFlowFromInvestingActivities":-846806000.0,"cashFlowFromFinancialActivities":-45582000.0,"changesInCashAndCashEquivalents":-366804000.0,"列1":"asr","submitDate":"2017\/11\/28","stockCode":2927,"accountingYear":"第37期（自? 平成28年９月１日? 至? 平成29年８月31日）","accountingYearStart":"2016\/9\/1","accountingYearEnd":"2017\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2018\/8\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":559.0,"averageTemporaryStaff":204.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4811820.0,"sharesOwendPercent":0.3421,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":686.37,"equityRatio":0.534,"cashAndCashEquivalents":3524507000.0,"assets":18060197000.0,"currentAssets":9206976000.0,"fixedAsset":8853220000.0,"tangibleFixedAssets":8064408000.0,"intangibleFixedAssets":95277000.0,"investmentAndOtherAssets":693534000.0,"liabilities":8407210000.0,"currentLiabilities":6240839000.0,"shorTermDept":2552533000.0,"currentPortionOfBonds":60000000.0,"currentPortionOfLongTermDebt":321048000.0,"fixedLiabilities":2166371000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1316728000.0,"netAsset":9652986000.0,"capitalStock":9680309000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":5411873000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-27322000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":15795643000.0,"costOfSales":11203039000.0,"grossProfit":4592603000.0,"sgaExpenses":3569120000.0,"salaryAndBenefit":1152361000.0,"depreciationAndSGA":null,"RDExpenses":139187000.0,"operatingIncome":1023483000.0,"nonOperatingIncome":50030000.0,"nonOperatingExpenses":91500000.0,"interestExpense":57841000.0,"ordinaryProfit":982012000.0,"extraordinaryGain":7587000.0,"extraordinaryLoss":3947000.0,"incomeBeforeTax":985653000.0,"incomeTaxes":248972000.0,"netIncome":736680000.0,"netIncomeAttributableToOwnersOfTheParentCompany":736680000.0,"comprehensiveIncome":718194000.0,"eps":58.28,"dilutedEps":null,"dividendPerShare":null,"per":12.3,"roe":0.085,"cashFlowFromOperatingActivities":1221626000.0,"depreciationAndCashflowFromOperatingActivities":436101000.0,"cashFlowFromInvestingActivities":-850065000.0,"cashFlowFromFinancialActivities":280168000.0,"changesInCashAndCashEquivalents":651729000.0,"列1":"asr","submitDate":"2018\/11\/27","stockCode":2927,"accountingYear":"第38期（自? 平成29年９月１日? 至? 平成30年８月31日）","accountingYearStart":"2017\/9\/1","accountingYearEnd":"2018\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2019\/2\/28","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4673420.0,"sharesOwendPercent":0.3323,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.552,"cashAndCashEquivalents":3421350000.0,"assets":18124036000.0,"currentAssets":9316059000.0,"fixedAsset":8807977000.0,"tangibleFixedAssets":7922326000.0,"intangibleFixedAssets":102321000.0,"investmentAndOtherAssets":783329000.0,"liabilities":8113288000.0,"currentLiabilities":6807664000.0,"shorTermDept":3600281000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1305624000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":547854000.0,"netAsset":10010747000.0,"capitalStock":10042035000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":5773599000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-31287000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":8338164000.0,"costOfSales":6012459000.0,"grossProfit":2325705000.0,"sgaExpenses":1727209000.0,"salaryAndBenefit":567483000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":598495000.0,"nonOperatingIncome":44142000.0,"nonOperatingExpenses":24727000.0,"interestExpense":18773000.0,"ordinaryProfit":617909000.0,"extraordinaryGain":95839000.0,"extraordinaryLoss":16449000.0,"incomeBeforeTax":697299000.0,"incomeTaxes":194936000.0,"netIncome":502363000.0,"netIncomeAttributableToOwnersOfTheParentCompany":502363000.0,"comprehensiveIncome":498398000.0,"eps":35.72,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":244904000.0,"depreciationAndCashflowFromOperatingActivities":228654000.0,"cashFlowFromInvestingActivities":-58359000.0,"cashFlowFromFinancialActivities":-289701000.0,"changesInCashAndCashEquivalents":-103156000.0,"列1":"q2r","submitDate":"2019\/4\/12","stockCode":2927,"accountingYear":null,"accountingYearStart":"2018\/9\/1","accountingYearEnd":"2019\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2019\/5\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.547,"cashAndCashEquivalents":null,"assets":18263164000.0,"currentAssets":9449552000.0,"fixedAsset":8813611000.0,"tangibleFixedAssets":7898351000.0,"intangibleFixedAssets":157338000.0,"investmentAndOtherAssets":757921000.0,"liabilities":8266524000.0,"currentLiabilities":7015576000.0,"shorTermDept":3600321000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1250948000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":513377000.0,"netAsset":9996640000.0,"capitalStock":10066687000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":5798252000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-70047000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":12219420000.0,"costOfSales":8786606000.0,"grossProfit":3432813000.0,"sgaExpenses":2594393000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":838420000.0,"nonOperatingIncome":58927000.0,"nonOperatingExpenses":35757000.0,"interestExpense":27767000.0,"ordinaryProfit":861590000.0,"extraordinaryGain":98584000.0,"extraordinaryLoss":14093000.0,"incomeBeforeTax":946081000.0,"incomeTaxes":278428000.0,"netIncome":667653000.0,"netIncomeAttributableToOwnersOfTheParentCompany":667653000.0,"comprehensiveIncome":624928000.0,"eps":47.47,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/7\/12","stockCode":2927,"accountingYear":null,"accountingYearStart":"2018\/9\/1","accountingYearEnd":"2019\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2019\/8\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":589.0,"averageTemporaryStaff":193.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4641920.0,"sharesOwendPercent":0.3301,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":718.86,"equityRatio":0.552,"cashAndCashEquivalents":3902201000.0,"assets":18327080000.0,"currentAssets":9629550000.0,"fixedAsset":8697530000.0,"tangibleFixedAssets":7856393000.0,"intangibleFixedAssets":148617000.0,"investmentAndOtherAssets":692520000.0,"liabilities":8217233000.0,"currentLiabilities":6896200000.0,"shorTermDept":2762533000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":830926000.0,"fixedLiabilities":1321033000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":485802000.0,"netAsset":10109847000.0,"capitalStock":10182327000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":5913891000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-72479000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":16252889000.0,"costOfSales":11732032000.0,"grossProfit":4520856000.0,"sgaExpenses":3539585000.0,"salaryAndBenefit":1143017000.0,"depreciationAndSGA":null,"RDExpenses":156620000.0,"operatingIncome":981271000.0,"nonOperatingIncome":80765000.0,"nonOperatingExpenses":47159000.0,"interestExpense":36516000.0,"ordinaryProfit":1014876000.0,"extraordinaryGain":98584000.0,"extraordinaryLoss":22436000.0,"incomeBeforeTax":1091024000.0,"incomeTaxes":307732000.0,"netIncome":783292000.0,"netIncomeAttributableToOwnersOfTheParentCompany":783292000.0,"comprehensiveIncome":738136000.0,"eps":55.7,"dilutedEps":null,"dividendPerShare":null,"per":11.7,"roe":0.079,"cashFlowFromOperatingActivities":1131930000.0,"depreciationAndCashflowFromOperatingActivities":472765000.0,"cashFlowFromInvestingActivities":-202217000.0,"cashFlowFromFinancialActivities":-546880000.0,"changesInCashAndCashEquivalents":377694000.0,"列1":"asr","submitDate":"2019\/11\/26","stockCode":2927,"accountingYear":"第39期（自? 2018年９月１日? 至? 2019年８月31日）","accountingYearStart":"2018\/9\/1","accountingYearEnd":"2019\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2019\/11\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.54,"cashAndCashEquivalents":null,"assets":18680450000.0,"currentAssets":9875504000.0,"fixedAsset":8804946000.0,"tangibleFixedAssets":7835673000.0,"intangibleFixedAssets":197560000.0,"investmentAndOtherAssets":771712000.0,"liabilities":8594377000.0,"currentLiabilities":7295416000.0,"shorTermDept":3584891000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1298960000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":459933000.0,"netAsset":10086072000.0,"capitalStock":10132775000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":5864339000.0,"treasuryStock":-59284000.0,"valuationAndConversionAdjustments":-46702000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":3853156000.0,"costOfSales":2696309000.0,"grossProfit":1156847000.0,"sgaExpenses":895324000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":261523000.0,"nonOperatingIncome":11411000.0,"nonOperatingExpenses":12525000.0,"interestExpense":8508000.0,"ordinaryProfit":260409000.0,"extraordinaryGain":175000.0,"extraordinaryLoss":5235000.0,"incomeBeforeTax":255349000.0,"incomeTaxes":93944000.0,"netIncome":161404000.0,"netIncomeAttributableToOwnersOfTheParentCompany":161404000.0,"comprehensiveIncome":187181000.0,"eps":11.48,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/1\/14","stockCode":2927,"accountingYear":null,"accountingYearStart":"2019\/9\/1","accountingYearEnd":"2020\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2020\/2\/29","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4699620.0,"sharesOwendPercent":0.3342,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.563,"cashAndCashEquivalents":3827067000.0,"assets":18248951000.0,"currentAssets":9556784000.0,"fixedAsset":8692167000.0,"tangibleFixedAssets":7757195000.0,"intangibleFixedAssets":190797000.0,"investmentAndOtherAssets":744174000.0,"liabilities":7983701000.0,"currentLiabilities":6026257000.0,"shorTermDept":2876323000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1957443000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1134064000.0,"netAsset":10265250000.0,"capitalStock":10324140000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":6055734000.0,"treasuryStock":-59314000.0,"valuationAndConversionAdjustments":-58890000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":7892851000.0,"costOfSales":5572711000.0,"grossProfit":2320139000.0,"sgaExpenses":1754860000.0,"salaryAndBenefit":552971000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":565279000.0,"nonOperatingIncome":26200000.0,"nonOperatingExpenses":23791000.0,"interestExpense":16839000.0,"ordinaryProfit":567688000.0,"extraordinaryGain":175000.0,"extraordinaryLoss":29301000.0,"incomeBeforeTax":538561000.0,"incomeTaxes":185762000.0,"netIncome":352799000.0,"netIncomeAttributableToOwnersOfTheParentCompany":352799000.0,"comprehensiveIncome":366388000.0,"eps":25.09,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":537846000.0,"depreciationAndCashflowFromOperatingActivities":246288000.0,"cashFlowFromInvestingActivities":-290110000.0,"cashFlowFromFinancialActivities":-327623000.0,"changesInCashAndCashEquivalents":-75134000.0,"列1":"q2r","submitDate":"2020\/4\/14","stockCode":2927,"accountingYear":null,"accountingYearStart":"2019\/9\/1","accountingYearEnd":"2020\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2020\/5\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.559,"cashAndCashEquivalents":null,"assets":18275417000.0,"currentAssets":9684986000.0,"fixedAsset":8590431000.0,"tangibleFixedAssets":7665805000.0,"intangibleFixedAssets":178467000.0,"investmentAndOtherAssets":746157000.0,"liabilities":8061800000.0,"currentLiabilities":6138233000.0,"shorTermDept":2867715000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1923566000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1108195000.0,"netAsset":10213617000.0,"capitalStock":10272525000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":6004119000.0,"treasuryStock":-59314000.0,"valuationAndConversionAdjustments":-58908000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":11673283000.0,"costOfSales":8282518000.0,"grossProfit":3390764000.0,"sgaExpenses":2601985000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":788779000.0,"nonOperatingIncome":39596000.0,"nonOperatingExpenses":42982000.0,"interestExpense":25080000.0,"ordinaryProfit":785392000.0,"extraordinaryGain":4271000.0,"extraordinaryLoss":99910000.0,"incomeBeforeTax":689753000.0,"incomeTaxes":247932000.0,"netIncome":441821000.0,"netIncomeAttributableToOwnersOfTheParentCompany":441821000.0,"comprehensiveIncome":455392000.0,"eps":31.42,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/7\/15","stockCode":2927,"accountingYear":null,"accountingYearStart":"2019\/9\/1","accountingYearEnd":"2020\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2020\/8\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":592.0,"averageTemporaryStaff":180.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5070620.0,"sharesOwendPercent":0.3605,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":744.04,"equityRatio":0.564,"cashAndCashEquivalents":4170642000.0,"assets":18548888000.0,"currentAssets":10009188000.0,"fixedAsset":8539699000.0,"tangibleFixedAssets":7659199000.0,"intangibleFixedAssets":162778000.0,"investmentAndOtherAssets":717721000.0,"liabilities":8084978000.0,"currentLiabilities":6204340000.0,"shorTermDept":2762533000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":103476000.0,"fixedLiabilities":1880638000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1082326000.0,"netAsset":10463909000.0,"capitalStock":10507387000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":6238981000.0,"treasuryStock":-59314000.0,"valuationAndConversionAdjustments":-43477000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":15819281000.0,"costOfSales":11264680000.0,"grossProfit":4554601000.0,"sgaExpenses":3460922000.0,"salaryAndBenefit":1082015000.0,"depreciationAndSGA":null,"RDExpenses":166359000.0,"operatingIncome":1093679000.0,"nonOperatingIncome":63389000.0,"nonOperatingExpenses":57239000.0,"interestExpense":32922000.0,"ordinaryProfit":1099829000.0,"extraordinaryGain":4271000.0,"extraordinaryLoss":99757000.0,"incomeBeforeTax":1004343000.0,"incomeTaxes":327659000.0,"netIncome":676683000.0,"netIncomeAttributableToOwnersOfTheParentCompany":676683000.0,"comprehensiveIncome":705685000.0,"eps":48.12,"dilutedEps":null,"dividendPerShare":null,"per":14.0,"roe":0.066,"cashFlowFromOperatingActivities":1299011000.0,"depreciationAndCashflowFromOperatingActivities":508926000.0,"cashFlowFromInvestingActivities":-458718000.0,"cashFlowFromFinancialActivities":-574936000.0,"changesInCashAndCashEquivalents":268440000.0,"列1":"asr","submitDate":"2020\/11\/25","stockCode":2927,"accountingYear":"第40期（自? 2019年９月１日? 至? 2020年８月31日）","accountingYearStart":"2019\/9\/1","accountingYearEnd":"2020\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2020\/11\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.544,"cashAndCashEquivalents":null,"assets":19393891000.0,"currentAssets":10911354000.0,"fixedAsset":8482537000.0,"tangibleFixedAssets":7676212000.0,"intangibleFixedAssets":148173000.0,"investmentAndOtherAssets":658150000.0,"liabilities":8847448000.0,"currentLiabilities":6988304000.0,"shorTermDept":2866009000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1859144000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1056457000.0,"netAsset":10546443000.0,"capitalStock":10589446000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":6473836000.0,"treasuryStock":-212110000.0,"valuationAndConversionAdjustments":-43003000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4637135000.0,"costOfSales":3199104000.0,"grossProfit":1438031000.0,"sgaExpenses":879431000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":558599000.0,"nonOperatingIncome":12639000.0,"nonOperatingExpenses":13322000.0,"interestExpense":7659000.0,"ordinaryProfit":557916000.0,"extraordinaryGain":null,"extraordinaryLoss":14800000.0,"incomeBeforeTax":543115000.0,"incomeTaxes":167623000.0,"netIncome":375491000.0,"netIncomeAttributableToOwnersOfTheParentCompany":375491000.0,"comprehensiveIncome":375966000.0,"eps":26.91,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/1\/14","stockCode":2927,"accountingYear":null,"accountingYearStart":"2020\/9\/1","accountingYearEnd":"2021\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2021\/2\/28","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4873400.0,"sharesOwendPercent":0.3519,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.546,"cashAndCashEquivalents":5435898000.0,"assets":20011860000.0,"currentAssets":11411409000.0,"fixedAsset":8600450000.0,"tangibleFixedAssets":7776856000.0,"intangibleFixedAssets":137057000.0,"investmentAndOtherAssets":686536000.0,"liabilities":9058922000.0,"currentLiabilities":7942266000.0,"shorTermDept":3661009000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1116655000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":340588000.0,"netAsset":10952937000.0,"capitalStock":10948382000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":6832772000.0,"treasuryStock":-212110000.0,"valuationAndConversionAdjustments":-25573000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":9150832000.0,"costOfSales":6325758000.0,"grossProfit":2825074000.0,"sgaExpenses":1809074000.0,"salaryAndBenefit":564344000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1016000000.0,"nonOperatingIncome":39476000.0,"nonOperatingExpenses":29186000.0,"interestExpense":15502000.0,"ordinaryProfit":1026290000.0,"extraordinaryGain":null,"extraordinaryLoss":546000.0,"incomeBeforeTax":1025743000.0,"incomeTaxes":291315000.0,"netIncome":734427000.0,"netIncomeAttributableToOwnersOfTheParentCompany":734427000.0,"comprehensiveIncome":752331000.0,"eps":52.83,"dilutedEps":52.7,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1715995000.0,"depreciationAndCashflowFromOperatingActivities":247403000.0,"cashFlowFromInvestingActivities":-183465000.0,"cashFlowFromFinancialActivities":-272890000.0,"changesInCashAndCashEquivalents":1265256000.0,"列1":"q2r","submitDate":"2021\/4\/14","stockCode":2927,"accountingYear":null,"accountingYearStart":"2020\/9\/1","accountingYearEnd":"2021\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2021\/5\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.347,"cashAndCashEquivalents":null,"assets":32879229000.0,"currentAssets":14302265000.0,"fixedAsset":18576963000.0,"tangibleFixedAssets":15324636000.0,"intangibleFixedAssets":1045149000.0,"investmentAndOtherAssets":2207177000.0,"liabilities":20675792000.0,"currentLiabilities":14110558000.0,"shorTermDept":6074108000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6565233000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5038975000.0,"netAsset":12203436000.0,"capitalStock":11399979000.0,"capital":2131839000.0,"capitalSurplus":2195880000.0,"accumulatedEarnings":7284369000.0,"treasuryStock":-212110000.0,"valuationAndConversionAdjustments":-318000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":14495207000.0,"costOfSales":9829899000.0,"grossProfit":4665307000.0,"sgaExpenses":2748360000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1916947000.0,"nonOperatingIncome":53530000.0,"nonOperatingExpenses":63163000.0,"interestExpense":23111000.0,"ordinaryProfit":1907314000.0,"extraordinaryGain":null,"extraordinaryLoss":3607000.0,"incomeBeforeTax":1903706000.0,"incomeTaxes":544560000.0,"netIncome":1359146000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1359146000.0,"comprehensiveIncome":1402305000.0,"eps":97.89,"dilutedEps":97.38,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/7\/15","stockCode":2927,"accountingYear":null,"accountingYearStart":"2020\/9\/1","accountingYearEnd":"2021\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2021\/8\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":793.0,"averageTemporaryStaff":339.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5080840.0,"sharesOwendPercent":0.358,"outstandingShares":null,"numberOfSubsidiary":13.0,"bps":833.44,"equityRatio":0.331,"cashAndCashEquivalents":8667136000.0,"assets":35752403000.0,"currentAssets":15852396000.0,"fixedAsset":19900007000.0,"tangibleFixedAssets":16011651000.0,"intangibleFixedAssets":1652628000.0,"investmentAndOtherAssets":2235726000.0,"liabilities":23091486000.0,"currentLiabilities":11802291000.0,"shorTermDept":3962533000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1027091000.0,"fixedLiabilities":11289195000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9691252000.0,"netAsset":12660917000.0,"capitalStock":11849746000.0,"capital":2131839000.0,"capitalSurplus":2438494000.0,"accumulatedEarnings":7420777000.0,"treasuryStock":-141364000.0,"valuationAndConversionAdjustments":-22380000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":22368076000.0,"costOfSales":15503067000.0,"grossProfit":6865008000.0,"sgaExpenses":4619768000.0,"salaryAndBenefit":1374256000.0,"depreciationAndSGA":null,"RDExpenses":163700000.0,"operatingIncome":2245239000.0,"nonOperatingIncome":90567000.0,"nonOperatingExpenses":173837000.0,"interestExpense":50040000.0,"ordinaryProfit":2161969000.0,"extraordinaryGain":549000.0,"extraordinaryLoss":4710000.0,"incomeBeforeTax":2157807000.0,"incomeTaxes":662358000.0,"netIncome":1495449000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1495554000.0,"comprehensiveIncome":1516546000.0,"eps":107.12,"dilutedEps":106.3,"dividendPerShare":null,"per":10.7,"roe":0.134,"cashFlowFromOperatingActivities":2582697000.0,"depreciationAndCashflowFromOperatingActivities":611631000.0,"cashFlowFromInvestingActivities":-274967000.0,"cashFlowFromFinancialActivities":2185303000.0,"changesInCashAndCashEquivalents":4496493000.0,"列1":"asr","submitDate":"2021\/11\/25","stockCode":2927,"accountingYear":"第41期（自? 2020年９月１日? 至? 2021年８月31日）","accountingYearStart":"2020\/9\/1","accountingYearEnd":"2021\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0},{"edinetCode":"E01064","endDate":"2021\/11\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.324,"cashAndCashEquivalents":null,"assets":36094994000.0,"currentAssets":16322646000.0,"fixedAsset":19772347000.0,"tangibleFixedAssets":15976729000.0,"intangibleFixedAssets":1602234000.0,"investmentAndOtherAssets":2193383000.0,"liabilities":23523481000.0,"currentLiabilities":11989432000.0,"shorTermDept":5725453000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":11534048000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9900424000.0,"netAsset":12571512000.0,"capitalStock":11762537000.0,"capital":2131839000.0,"capitalSurplus":2438494000.0,"accumulatedEarnings":7534374000.0,"treasuryStock":-342171000.0,"valuationAndConversionAdjustments":-56453000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":5454291000.0,"costOfSales":3395843000.0,"grossProfit":2058447000.0,"sgaExpenses":1892429000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":166018000.0,"nonOperatingIncome":182571000.0,"nonOperatingExpenses":32038000.0,"interestExpense":16763000.0,"ordinaryProfit":316551000.0,"extraordinaryGain":176000.0,"extraordinaryLoss":15584000.0,"incomeBeforeTax":301143000.0,"incomeTaxes":145098000.0,"netIncome":156045000.0,"netIncomeAttributableToOwnersOfTheParentCompany":156213000.0,"comprehensiveIncome":121972000.0,"eps":11.04,"dilutedEps":10.97,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2022\/1\/14","stockCode":2927,"accountingYear":null,"accountingYearStart":"2021\/9\/1","accountingYearEnd":"2022\/8\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01064","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1405,"settlementDate":"2022\/8\/31","submitterName":"株式会社ＡＦＣ－ＨＤアムスライフサイエンス","submitterNameEnglish":"AFC-HD AMS Life Science Co.,Ltd.","submitterNameKana":"カブシキガイシャエーエフシーエイチディーアムスライフサイエンス","location":"静岡市駿河区豊田３丁目６番３６号","industory":"食料品","corporateNumber":3080000000000.0}]